Infantile Hemiconvulsion-Hemiplegia and Epilepsy (IHHE) in a boy with tuberous sclerosis complex

Chariton Moschopoulos1, Jurriaan M Peters1, Masanori Takeoka1

  • 1Department of Neurology, Division of Epilepsy and Clinical Neurophysiology, Boston Children's Hospital, Harvard Medical School, 300 Longwood Avenue, Boston, MA 02115, USA.

Epilepsy & Behavior Reports
|September 1, 2021
PubMed

Insights

Tuberous sclerosis complex (TSC) can lead to new-onset refractory status epilepticus (NORSE), specifically Infantile Hemiconvulsion-Hemiplegia and Epilepsy (IHHE). This case highlights brain malformations and suggests a potential genetic inflammatory predisposition in TSC patients with IHHE.

Area of Science:

  • Neurology
  • Genetics
  • Pediatrics

Background:

  • Tuberous sclerosis complex (TSC) is an autosomal dominant disorder caused by TSC1 or TSC2 gene variants.
  • TSC involves brain malformations like tubers and abnormal neuronal migration, leading to epilepsy in 80% of patients within the first two years.
  • Systemic illness and fever can precipitate seizures, potentially causing status epilepticus in individuals with epilepsy.

Observation:

  • Infantile Hemiconvulsion-Hemiplegia and Epilepsy (IHHE), a subset of new-onset refractory status epilepticus (NORSE), is characterized by hemiclonic seizures, fever, unilateral brain abnormalities, and hemiparesis.
  • This report details an 18-month-old boy with TSC who experienced IHHE.
  • The patient presented with extensive brain malformations and neuronal hyperexcitability in peri-tuberal tissues.

Findings:

  • The patient's TSC-related brain malformations and neuronal hyperexcitability likely predisposed him to developing IHHE.
  • The occurrence of IHHE in this TSC patient suggests that these neurological factors are critical.
  • The study postulates an additional, yet unidentified, genetic predisposition for an exaggerated inflammatory response as a prerequisite for IHHE in TSC.

Implications:

  • This case expands the understanding of IHHE presentation within the context of Tuberous Sclerosis Complex.
  • It emphasizes the role of underlying brain architecture and neuronal excitability in seizure disorder development.
  • Further research into the genetic basis of inflammatory responses in TSC may reveal novel therapeutic targets for preventing or managing severe epilepsy syndromes like IHHE.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
696
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
376
Electroconvulsive Therapy01:30

Electroconvulsive Therapy

Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
278
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
347